Citrate transport protein (SLC25A1) Human shRNA Plasmid Kit (Locus ID 6576)
CAT#: TG316728
SLC25A1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Citrate transport protein (SLC25A1) Human shRNA Plasmid Kit (Locus ID 6576) |
Locus ID | 6576 |
UniProt ID | P53007 |
Synonyms | CMS23; CTP; D2L2AD; SEA; SLC20A3 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | SLC25A1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 6576). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_001256534, NM_001287387, NM_005984, NR_033687, NR_046298, NM_005984.1, NM_005984.2, NM_005984.3, NM_005984.4, NM_001256534.1, NM_001287387.1, BC008061, BC008061.2, BC004980, BC018590, BM679710, NM_001287387.2, NM_005984.5, NM_001256534.2 |
Summary | This gene encodes a member of the mitochondrial carrier subfamily of solute carrier proteins. Members of this family include nuclear-encoded transporters that translocate small metabolites across the mitochondrial membrane. This protein regulates the movement of citrate across the inner membranes of the mitochondria. Mutations in this gene have been associated with combined D-2- and L-2-hydroxyglutaric aciduria. Pseudogenes of this gene have been identified on chromosomes 7, 11, 16, and 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker
,null,
Oncotarget
,PubMed ID 24681808
[SLC25A1]
|
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis
,null,
Oncotarget
,PubMed ID 23100451
[SLC25A1]
|
Documents
Product Manuals |
FAQs |
SDS |
其它SLC25A1产品
Customer
Reviews
Loading...